Bhumi Jambuka: Benefits, Evidence & Safety

TL;DR

Bhumi-jambuka (Premna herbacea) is a low-growing Ayurvedic herb used by Bodo folk healers in Assam for fever, pain, and inflammation. The lab work looks interesting: a root extract lowered blood sugar in diabetic rats, and isolated isoverbascoside improved glucose uptake in muscle cells. But no human trials exist.

What it is

I traced this one through Kew's Medicinal Plant Names Services, which maps "bhumi-jambuka" to the accepted name Premna herbacea Roxb., an Indian medicinal-plants database entry from TDU, 2020. Classical Sanskrit dictionaries agree: Monier-Williams defines "bhumijambuka" as a kind of Premna, a bushy shrub (Kew MPNS; Wisdom Library). It's a low-growing herb of the Lamiaceae family, formerly placed in Verbenaceae. Synonyms include Premna nana, P. sessilifolia and P. obovata. Folk names run to Gethiaa, Ghantu Bhaarangi, and (in Assam) Mati-galdabin/Mati-feurain. It shows up as an ingredient of the Ayurvedic proprietary formulation Deliwin Legiyam (AyurMedInfo). Authentication warning: an Indian medicinal-plant dictionary notes that P. herbacea roots are frequently confused with or substituted by Clerodendrum serratum roots. Buy only authenticated material (yumpu.com scan of Indian Medicinal Plants: An Illustrated Dictionary).

Traditional use

In Assam, Bodo community healers use P. herbacea for many disorders including diabetes, and its leaves and roots are used in folk medicine for headache, rheumatic pain, cough, fever, cold, ulcers, gout, sprains, asthma and cholera (ResearchGate review). A genus-level survey of Premna reports species including P. herbacea for asthma, rheumatism, neuralgia, diarrhea, stomach disorders, hyperglycemia, obesity, and as a post-delivery tonic (PMC, Review of the genus Premna). The leaves have been used for fever, cough and rheumatism and in poultices for boils (StuartXchange). All of this is traditional and folk material. I found no human clinical trials testing any of it.

What modern research says

Blood sugar (animal and cell studies only)

In Sprague-Dawley rats fed a high-fat/high-fructose diet and in cultured L6 muscle cells, a methanolic extract of P. herbacea roots showed antidiabetic activity, and the isolated compound isoverbascoside (reportedly first isolated from the genus Premna) improved glucose uptake and reduced blood glucose, with the mechanism probed in muscle cells (cell and diabetic-rat study, PMID 34715512). Separately, several novel compounds isolated from P. herbacea were investigated for antidiabetic potential in laboratory assays and a streptozotocin-nicotinamide rat model (PMID 33824103). Preclinical, all of it. These findings do not establish blood-sugar benefits in people, and I found no human trials.

Inflammation and psoriasis-like skin inflammation (animal study)

In splenic macrophages, a methanolic P. herbacea root extract reduced lipopolysaccharide-induced reactive oxygen species (in vitro), and in male BALB/c mice it ameliorated imiquimod-induced psoriasis-like skin inflammation, assessed by flow cytometry, RT-PCR and confocal imaging (in-vitro and mouse study, PMID 37549537). Interesting work. It is an animal model of inflammation, not evidence for treating psoriasis in humans.

Fever and inflammation (older animal studies)

An alcoholic root extract showed antipyretic effects in rabbits, mild pain-relieving (antinociceptive) effects in mice, and significant effects in a chronic-inflammation animal model (animal study, PMID 10727811). Root-nodule extracts and fractions also showed in-vitro cytotoxicity and in-vivo antitumor activity in mice with Ehrlich ascites carcinoma and Dalton's lymphoma ascites tumours (mouse study, PMID 21920724). That is a laboratory finding, not cancer-treatment evidence.

What the evidence does not support (yet)

No human clinical trials of Premna herbacea were identified. Its traditional uses for diabetes, asthma, rheumatism, ulcers and post-delivery care rest entirely on folk and classical sources, not on clinical evidence.

Dosage

No pharmacopoeial (API/AFI) dose and no human-trial dose for bhumi-jambuka was identified. The existing research used extracts in animals and cell cultures at laboratory doses, which cannot be translated into a human dose. No dosage is given here. Do not self-dose; consult a qualified practitioner.

Safety & contraindications

There are no human safety, toxicity, drug-interaction, pregnancy, breastfeeding, or pediatric data for Premna herbacea. The only toxicity information I found is an animal finding: the root extract was safe up to 8 g/kg in mice (primary study). Mice are not people, and this does not establish human safety. The documented confusion of P. herbacea roots with Clerodendrum serratum makes product authentication important (yumpu.com scan of Indian Medicinal Plants: An Illustrated Dictionary). Safety data is limited. Talk to a clinician.

FAQs

What is bhumi-jambuka?

Bhumi-jambuka is the Sanskrit name for Premna herbacea Roxb., a low-growing Lamiaceae herb, confirmed by Kew's Medicinal Plant Names Services and classical Sanskrit dictionaries (Kew MPNS). Its roots and leaves are used in Assamese folk medicine and in Ayurvedic practice.

What is bhumi-jambuka used for in Ayurveda?

Traditional and folk uses include fever, headache, rheumatic pain, cough, asthma, diarrhea, ulcers and cholera, and the Bodo healers of Assam use it for diabetes among many disorders (ResearchGate review). It is also an ingredient of the formulation Deliwin Legiyam. All are traditional claims, not clinically proven uses.

Does bhumi-jambuka lower blood sugar?

Only in animals so far. A methanolic root extract lowered blood glucose in diabetic rats, and the isolated compound isoverbascoside improved glucose uptake in cultured muscle cells (PMID 34715512). I found no human trial, so there is no evidence it lowers blood sugar in people.

Does it help psoriasis or inflammation?

In mice, a root extract calmed imiquimod-induced psoriasis-like skin inflammation, and it reduced inflammatory markers in cultured macrophages (PMID 37549537). That is an animal model, not proof of benefit for human psoriasis or inflammatory conditions.

What is the safe dose of bhumi-jambuka?

No human dose has been established. No pharmacopoeial dose and no human-trial regimen exist. Animal studies used laboratory extracts that cannot be converted into a human dose (PMID 34715512). Do not self-dose; consult a qualified practitioner if considering it.

Is bhumi-jambuka safe in pregnancy or breastfeeding?

There are no published safety data for pregnancy, breastfeeding, or children. The only toxicity finding (root extract safe to 8 g/kg) comes from mice (primary study), which does not establish human safety. Avoid without clinical guidance.

Sources

This article is for educational purposes only and is not medical advice. Consult a qualified practitioner before using any Ayurvedic formulation.